Zobrazeno 1 - 4
of 4
pro vyhledávání: '"G. A. Isinova"'
Autor:
E. S. Kotova, O. A. Gavrilina, I. A. Yakutik, A. B. Sudarikov, Yu. A. Chabaeva, S. M. Kulikov, S. G. Beksaev, V. V. Troitskaya, G. A. Isinova, A. N. Sokolov, Z. T. Fidarova, I. A. Lukyanova, A. V. Abramova, V. N. Dvirnyk, I. V. Galtseva, T. N. Obukhova, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 17, Iss 3, Pp 98-107 (2022)
Background. 6-mercaptopurine (6-MP) is a drug that is included in the treatment protocols for children and adults with acute lymphoblastic leukemias/lymphomas (ALL/LBL). It is known that individual differences in 6-MP tolerance can be explained by th
Externí odkaz:
https://doaj.org/article/258f0daa502345c7a75d1d9529faa844
Autor:
K. I. Zarubina, E. N. Parovichnikova, V. L. Surin, O. S. Pshenichnikova, O. A. Gavrilina, G. A. Isinova, V. V. Troitskaia, A. N. Sokolov, I. V. Gal’tseva, N. M. Kapranov, Iu. O. Davydova, T. N. Obukhova, A. B. Sudarikov, V. G. Savchenko
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 31-42 (2020)
Issue.The study of activating mutations (NRAS,KRAS,FLT3,JAK2,CRLF2genes) of RAS/RAF/MEK/ERK and JAK/STAT signaling pathways in B-cell acute lymphoblastic leukemia (B-ALL) in adult patients which are included in Russian multicenter clinical trials.
Externí odkaz:
https://doaj.org/article/9c2f567d281a4179aa2fc45866e4cb30
Autor:
O. A. Aleshina, I. V. Galtseva, E. S. Kotova, G. I. Isinova, T. N. Obukhova, V. N. Dvirnik, A. B. Sudarikov, M. E. Grishunina, O. S. Samoilova, K. D. Kaplanov, V. A. Lapin, S. N. Bondarenko, E. S. Fokina, N. V. Minaeva, T. S. Konstantinova, Yu. V. Sveshnikova, E. E. Zinina, A. S. Antipova, O. Yu. Baranova, E. A. Borisenkova, Yu. O. Davydova, N. M. Kapranov, S. M. Kulikov, Yu. A. Chabaeva, V. V. Troitskaya, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 18, Iss 1, Pp 20-30 (2023)
Background. The effectiveness of therapy for acute T-lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL) has significantly improved over the past decades, including through the implementation of hematopoietic stem cell transplantation
Externí odkaz:
https://doaj.org/article/ae6ce0a734c64904adb16a244596e630
Autor:
E. N. Parovichnikova, O. A. Aleshina, V. V. Troitskaya, Yu. A. Chabaeva, A. N. Sokolov, G. A. Isinova, E. S. Kotova, Z. H. Akhmerzaeva, G. A. Klyasova, I. V. Galtseva, Yu. O. Davydova, L. A. Kuzmina, S. N. Bondarenko, O. Yu. Baranova, A. S. Antipova, O. S. Samoilova, M. E. Grishunina, K. D. Kaplanov, T. S. Kaporskaya, T. S. Konstantinova, Yu. V. Sveshnikova, E. A. Borisenkova, E. S. Fokina, N. V. Minaeva, E. E. Zinina, V. A. Lapin, E. O. Gribanova, E. E. Zvonkov, V. N. Dvirnyk, G. M. Galstyan, T. N. Obukhova, A. B. Sudarikov, S. M. Kulikov
Publikováno v:
Russian journal of hematology and transfusiology. 67:460-477
Introduction. Over the past 5 years, signifi cant progress has been achieved in the treatment of patients with Ph-negative acute lymphoblastic leukemia (ALL). Treatment results were compared between two protocols of the Russian multicenter studies «
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83008d7f13414967e0a7c982dd410338
https://doi.org/10.35754/0234-5730-2022-67-4-460-477
https://doi.org/10.35754/0234-5730-2022-67-4-460-477